Know Cancer

or
forgot password

Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Colon Cancer, Rectal Cancer, Colorectal Cancer

Thank you

Trial Information

Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer


Inclusion Criteria:



- Patients with (residual) oligometastatic CRC: ≤ 5 mets

- Primary tumor treated with curative intention (surgery, radiotherapy,
chemoradiotherapy)

- Functional liver volume > 1000cc if livermets, lung DLCO > 30% if lungmets.

- No Child B or C liver cirrhosis

- No contra-indications for radiation of all metastatic CRC (= no violation of
constraints of organs at risk (OAR))

- No mets from another carcinoma

- Age > 18 years

- WHO-PS ≤ 2

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Metabolic complete remission rate

Outcome Time Frame:

Three months

Safety Issue:

No

Principal Investigator

Mark De Ridder, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie

Authority:

Belgium: Federal Agency for Medicinal Products and Health Products

Study ID:

RCT501

NCT ID:

NCT00807313

Start Date:

December 2008

Completion Date:

July 2011

Related Keywords:

  • Colon Cancer
  • Rectal Cancer
  • Colorectal Cancer
  • Oligometastatic disease
  • Colorectal cancer
  • Stereotactic body radiotherapy
  • Tomotherapy
  • Metabolic response
  • Stage IV
  • Colonic Neoplasms
  • Rectal Neoplasms
  • Colorectal Neoplasms

Name

Location